Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

More than an anticoagulant: Do heparins have direct anti-inflammatory effects?
Timothy J. Poterucha, Peter Libby, Samuel Z. Goldhaber
Thrombosis and Haemostasis (2016) Vol. 117, Iss. 03, pp. 437-444
Closed Access | Times Cited: 192

Showing 1-25 of 192 citing articles:

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Ning Tang, Huan Bai, Xing Chen, et al.
Journal of Thrombosis and Haemostasis (2020) Vol. 18, Iss. 5, pp. 1094-1099
Open Access | Times Cited: 3637
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
Jecko Thachil, Ning Tang, Satoshi Gando, et al.
Journal of Thrombosis and Haemostasis (2020) Vol. 18, Iss. 5, pp. 1023-1026
Open Access | Times Cited: 1904
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
Ewan C. Goligher, Charlotte Bradbury, Bryan J. McVerry, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 9, pp. 777-789
Open Access | Times Cited: 849
The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
Mouhamed Yazan Abou‐Ismail, Akiva Diamond, Sargam Kapoor, et al.
Thrombosis Research (2020) Vol. 194, pp. 101-115
Open Access | Times Cited: 647
The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications
James D. McFadyen, Hannah Stevens, Karlheinz Peter
Circulation Research (2020) Vol. 127, Iss. 4, pp. 571-587
Open Access | Times Cited: 563
Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
Shiyu Yin, Ming Huang, Dengju Li, et al.
Journal of Thrombosis and Thrombolysis (2020) Vol. 51, Iss. 4, pp. 1107-1110
Open Access | Times Cited: 439
The versatile heparin in COVID‐19
Jecko Thachil
Journal of Thrombosis and Haemostasis (2020) Vol. 18, Iss. 5, pp. 1020-1022
Open Access | Times Cited: 412
Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms
Bruno Andrade, Sérgio Siqueira, Wagner Rodrigues de Assis Soares, et al.
Viruses (2021) Vol. 13, Iss. 4, pp. 700-700
Open Access | Times Cited: 401
Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms
Gregorio Tersalvi, Marco Vicenzi, Davide Calabretta, et al.
Journal of Cardiac Failure (2020) Vol. 26, Iss. 6, pp. 470-475
Open Access | Times Cited: 332
Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors
Mathieu Artifoni, Gwenvael Danic, Giovanni Gautier, et al.
Journal of Thrombosis and Thrombolysis (2020) Vol. 50, Iss. 1, pp. 211-216
Open Access | Times Cited: 282
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
Mahesh V. Madhavan, Behnood Bikdeli, Aakriti Gupta, et al.
Thrombosis and Haemostasis (2020) Vol. 120, Iss. 07, pp. 1004-1024
Open Access | Times Cited: 243
Thrombotic complications of COVID-19
Jacob Avila, Brit Long, Dallas Holladay, et al.
The American Journal of Emergency Medicine (2020) Vol. 39, pp. 213-218
Open Access | Times Cited: 140
The Role of Anticoagulation in COVID-19-Induced Hypercoagulability
Juan Simón Rico-Mesa, Daniel Rosas, Ashkan Ahmadian-Tehrani, et al.
Current Cardiology Reports (2020) Vol. 22, Iss. 7
Open Access | Times Cited: 139
Hematological Abnormalities in COVID-19: A Narrative Review
Asma Rahman, Roshan Niloofa, Umesh Jayarajah, et al.
American Journal of Tropical Medicine and Hygiene (2021) Vol. 104, Iss. 4, pp. 1188-1201
Open Access | Times Cited: 109
Heparin: An old drug for new clinical applications
Peipei Wang, Lianli Chi, Zhenqing Zhang, et al.
Carbohydrate Polymers (2022) Vol. 295, pp. 119818-119818
Closed Access | Times Cited: 86
COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure
Monia Marchetti
Annals of Hematology (2020) Vol. 99, Iss. 8, pp. 1701-1707
Open Access | Times Cited: 132
COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking
Giuseppe Magro
Virus Research (2020) Vol. 286, pp. 198070-198070
Open Access | Times Cited: 130
D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review
Sofia Vidali, Daniele Morosetti, Elsa Cossu, et al.
ERJ Open Research (2020) Vol. 6, Iss. 2, pp. 00260-2020
Open Access | Times Cited: 129
Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ?
Vanessa Bianconi, Francesco Violi, Francesca Fallarino, et al.
Drugs (2020) Vol. 80, Iss. 14, pp. 1383-1396
Open Access | Times Cited: 125
Coagulopathy in COVID-19: Manifestations and management
Simon Mucha, Siddharth Dugar, Keith R. McCrae, et al.
Cleveland Clinic Journal of Medicine (2020) Vol. 87, Iss. 8, pp. 461-468
Open Access | Times Cited: 123
COVID-19 Related Coagulopathy: A Distinct Entity?
Benjamin Marchandot, Laurent Sattler, Laurence Jesel, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 6, pp. 1651-1651
Open Access | Times Cited: 106
The looming storm: Blood and cytokines in COVID-19
Supreet Kaur, Rashika Bansal, Sudarsan Kollimuttathuillam, et al.
Blood Reviews (2020) Vol. 46, pp. 100743-100743
Open Access | Times Cited: 100
The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial
Christina U. Lorentz, Erik I. Tucker, Norah G. Verbout, et al.
Blood (2021) Vol. 138, Iss. 22, pp. 2173-2184
Open Access | Times Cited: 94
Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19)
Francesca Salamanna, Melania Maglio, Maria Paola Landini, et al.
Platelets (2020) Vol. 31, Iss. 5, pp. 627-632
Closed Access | Times Cited: 86
Therapeutic Anticoagulation in Critically Ill Patients with Covid-19 – Preliminary Report
Ryan Zarychanski
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 77
Page 1 - Next Page

Scroll to top